Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Dalian
Clinical trial register · China

Clinical Trials in Dalian, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Beijing 70 Guangzhou 60 Chengdu 58 Hangzhou 44 Chongqing 39
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca18 The First Affiliated Hospital of Dalian Medical University6 Beijing Anzhen Hospital4 Sun Yat-sen University4 Boehringer Ingelheim3 The First Affiliated Hospital with Nanjing Medical University3 Bristol-Myers Squibb3 Peking Union Medical College Hospital2 First Hospital of China Medical University2 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.2 City of Hope Medical Center2 Daiichi Sankyo2 Shanghai Zhongshan Hospital2 Medtronic2 Xinqiao Hospital of Chongqing2 Suez Canal University2 AbbVie2 Fudan University2 Excyte Biopharma Ltd2 Shengjing Hospital2 Xynomic Pharmaceuticals, Inc.2 Chinese Academy of Medical Sciences, Fuwai Hospital2 Janssen Research & Development, LLC2 Beijing Shijitan Hospital, Capital Medical University2 Xijing Hospital1 The Third Peoples Hospital of Dalian1 Shanghai Institute Of Biological Products1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd.1 Atom Therapeutics Co., Ltd1 Pierre Fabre Medicament1 Fujian Cancer Hospital1 ADC Therapeutics S.A.1 Beijing Friendship Hospital1 First Affiliated Hospital of Zhejiang University1 Eli Lilly and Company1 Acerta Pharma BV1 Xingshun Qi1 CSL Behring1 Bio-Thera Solutions1 Beeline Medicines Corporation1 Xiamen Ophthalmology Center Affiliated to Xiamen University1 Fujian Medical University1 Ton-Bridge Medical Tech. Co., Ltd1 Shuangyue Liu1 Dizal Pharmaceuticals1 Novartis Pharmaceuticals1 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1 Beijing InnoCare Pharma Tech Co., Ltd.1 First Affiliated Hospital Xi'an Jiaotong University1 The Second Affiliated Hospital of Dalian Medical University1 Harbin Medical University1 wanghaibo1 Chinese SLE Treatment And Research Group1 Shandong Suncadia Medicine Co., Ltd.1 Qilu Pharmaceutical Co., Ltd.1 Chen Xiangmei1 Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1 Dalian Municipal Central Hospital1 InnoCare Pharma Inc.1 Institute of Hematology & Blood Diseases Hospital, China1 Peking University Cancer Hospital & Institute1 Sanofi1 Zai Lab (Shanghai) Co., Ltd.1 Xiamen Amoytop Biotech Co., Ltd.1 Southeast University, China1 Stephen Nicholls1 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.1 Dalian Medical University1 Obstetrics & Gynecology Hospital of Fudan University1 Shanghai Haiyan Pharmaceutical Technology Co., Ltd.1 Huashan Hospital1 Liu yong1 BeOne Medicines1 China Medical University, China1 BioNTech SE1 Dr. Willmar Schwabe GmbH & Co. KG1 Genmab1 Klus Pharma Inc.1 Vertex Pharmaceuticals Incorporated1 Biotheus Inc.1 Beijing Northland Biotech. Co., Ltd.1 Zhang Jianguo1 BYHEALTH Co., LTD1 Qilu Hospital of Shandong University1 Clear sponsor filter
Target enrolment
to

Trials with a site in Dalian

2 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Janssen Research & Development, LLC
Phase 1/2
225
Dalian, Guangzhou, Hangzhou, Wuhan
2022-07-29
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Beijing, Changchun, Changsha, Chengdu, Chongqing, Dalian, Ganzhou, Guangzhou
2019-09-26
Rows per page Showing 1–2 of 2
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/dalian

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2 of those studies with a site in Dalian that also match the filters currently applied.

How many clinical trials are recruiting in Dalian?

1 of the 2 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Dalian), 2 studies
PhaseStudiesRecruitingShare
Phase 1/21150%
Phase 2/31050%

Most active sponsors

Lead sponsors with the most studies (Dalian)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.